Literature DB >> 18846330

Homocysteine-induced enhanced expression of tissue factor in human vascular smooth muscle cells.

Fang Liu1, Ruibin Huang, Junxia Yao, Wenning Wei, Yu Hu, Shanjun Song, Jun Li.   

Abstract

The homocysteine (Hcy)-induced tissue factor (TF) expression in human vascular smooth muscle cells (VSMCs) and the effect of Hcy on the activity of nuclear factor-kappaB (NF-kappaB) and the expression of inducible nitric oxide synthase (iNOS) were investigated. Human umbilical artery VSMCs were cultured by tissue explanting method, identified by alpha-actin immunohistochemistry, and incubated with different concentrations of Hcy/PTDC (NF-kappaB inhibitor). Semi-quantitative RT-PCR was performed to detect the expression of TF mRNA in VSMCs. Flow cytometry was used to assay the expression of TF protein on the surface of VSMCs and the expression of iNOS in VSMCs. Western blot was carried out to detect the expression of NF-kappaB protein in nuclei. The results showed that Hcy could induce VSMCs expressing TF mRNA significantly after the VSMCs were incubated with Hcy at concentrations of 10, 100, 500 micromol/L respectively. There was low expression level of TF protein on the surface of the resting VSMCs and Hcy could also induce VSMCs expressing TF protein on the cell surface in different concentrations. Additionally, Hcy could rapidly induce the activation of NF-kappaB and this effect could be significantly inhibited by PDTC. Hcy alone could not induce the expression of iNOS in VSMCs. It was concluded that Hcy could significantly induce the expression of TF in VSMCs and enhance the activation of NF-kappaB, subsequently mediate TF gene expression and protein synthesis. NF-kappaB-mediated expression of TF in VSMCs might be the important mechanism of atherosclerosis and thrombosis induced by Hcy.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18846330     DOI: 10.1007/s11596-008-0507-9

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  19 in total

1.  Activated nuclear factor-kappaB is present in the coronary vasculature in experimental hypercholesterolemia.

Authors:  S H Wilson; N M Caplice; R D Simari; D R Holmes; P J Carlson; A Lerman
Journal:  Atherosclerosis       Date:  2000-01       Impact factor: 5.162

2.  Augmented expression of inducible NO synthase in vascular smooth muscle cells during aging is associated with enhanced NF-kappaB activation.

Authors:  Z Q Yan; A Sirsjö; M L Bochaton-Piallat; G Gabbiani; G K Hansson
Journal:  Arterioscler Thromb Vasc Biol       Date:  1999-12       Impact factor: 8.311

Review 3.  Hyperhomocysteinemia: an additional cardiovascular risk factor.

Authors:  P C Fanapour; B Yug; M S Kochar
Journal:  WMJ       Date:  1999-12

4.  Localization and activity of tissue factor in human aortic atherosclerotic lesions.

Authors:  K Hatakeyama; Y Asada; K Marutsuka; Y Sato; Y Kamikubo; A Sumiyoshi
Journal:  Atherosclerosis       Date:  1997-09       Impact factor: 5.162

5.  Macrophages, smooth muscle cells, and tissue factor in unstable angina. Implications for cell-mediated thrombogenicity in acute coronary syndromes.

Authors:  P R Moreno; V H Bernardi; J López-Cuéllar; A M Murcia; I F Palacios; H K Gold; R Mehran; S K Sharma; Y Nemerson; V Fuster; J T Fallon
Journal:  Circulation       Date:  1996-12-15       Impact factor: 29.690

6.  Homocysteine increases nitric oxide synthesis in cytokine-stimulated vascular smooth muscle cells.

Authors:  U Ikeda; M Ikeda; S Minota; K Shimada
Journal:  Circulation       Date:  1999-03-09       Impact factor: 29.690

7.  Hyperhomocystinemia in patients with coronary artery disease.

Authors:  J R Faria-Neto; A C P Chagas; S P Bydlowski; P A Lemos Neto; D A Chamone; J A F Ramirez; P L da Luz
Journal:  Braz J Med Biol Res       Date:  2006-04-03       Impact factor: 2.590

8.  Role of nuclear factor-kappaB activation in cytokine- and sphingomyelinase-stimulated inducible nitric oxide synthase gene expression in vascular smooth muscle cells.

Authors:  K Katsuyama; M Shichiri; F Marumo; Y Hirata
Journal:  Endocrinology       Date:  1998-11       Impact factor: 4.736

9.  Identification of active tissue factor in human coronary atheroma.

Authors:  J D Marmur; S V Thiruvikraman; B S Fyfe; A Guha; S K Sharma; J A Ambrose; J T Fallon; Y Nemerson; M B Taubman
Journal:  Circulation       Date:  1996-09-15       Impact factor: 29.690

10.  Vasoactive substances regulate vascular smooth muscle cell apoptosis. Countervailing influences of nitric oxide and angiotensin II.

Authors:  M J Pollman; T Yamada; M Horiuchi; G H Gibbons
Journal:  Circ Res       Date:  1996-10       Impact factor: 17.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.